Author:
Lin Dawei,Li Mingfei,Weng Zilong,Pan Wenzhi,Zhou Daxin,Ge Junbo
Abstract
AbstractPatients with previous interatrial shunt device (IASD) implantation may face greater challenges during future left atrial interventional procedures. Herein, we report the first case of left atrial appendage closure (LAAC) in a patient with previous IASD implantation. The patient successfully underwent LAAC using the LAmbre device without complications.
Funder
National Key Research and Development Program of China
Shanghai Clinical Research Center for Interventional Medicine
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage Closure Versus Direct oral anticoagulants in high-risk patients with Atrial Fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35.
2. Al-Abcha A, Saleh Y, Elsayed M, Elshafie A, Herzallah K, Baloch ZQ, et al. Left atrial appendage Closure Versus oral anticoagulation in Non-valvular Atrial Fibrillation: a systematic review and Meta-analysis. Cardiovasc Revasc Med. 2022;36:18–24.
3. Xipell M, Flores-Umanzor E, Ojeda R, Arias M, Cepas-Guillen PL, Regueiro A, et al. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: a single center experience. Artif Organs. 2020;44(5):513–21.
4. Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, et al. Primary outcome evaluation of a Next-Generation Left Atrial Appendage Closure device: results from the PINNACLE FLX Trial. Circulation. 2021;143(18):1754–62.
5. Du H, Bi K, Xu L, Chen F, Xiong W, Wang Y. Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation. Cardiovasc J Afr. 2021;32(3):116–22.